Quick Answer
Arcturus Therapeutics Holdings Inc. reported Net Income of -$65.78 million for fiscal year 2025.
Arcturus Therapeutics Holdings Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$65.78M | +18.7% |
| 2024 | -$80.94M | -172.3% |
| 2023 | -$29.73M | -417.9% |
| 2022 | $9.35M | +104.6% |
| 2021 | -$203.67M | -182.3% |
| 2020 | -$72.15M | -177.6% |
| 2019 | -$25.99M | -19.3% |
| 2018 | -$21.79M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$13.45M | -94.8% | -46.5% |
| June 30, 2025 | -$9.18M | +46.7% | +34.8% |
| March 31, 2025 | -$14.08M | +47.5% | -103.9% |
| September 30, 2024 | -$6.90M | +57.4% | +59.9% |
| June 30, 2024 | -$17.22M | +67.2% | +35.8% |
| March 31, 2024 | -$26.82M | -152.8% | -65.3% |
| September 30, 2023 | -$16.22M | +54.0% | +69.1% |
| June 30, 2023 | -$52.55M | -143.7% | -203.5% |
- Arcturus Therapeutics Holdings Inc. showed an increase of +18.7% in Net Income compared to the prior fiscal year.
- Over the 2018–2025 period, Arcturus Therapeutics Holdings Inc.’s net income has declined by 202.0% (from -$21.79 million to -$65.78 million).
- The most recent figure is from Arcturus Therapeutics Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: